Viewing StudyNCT00002947



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002947
Status: TERMINATED
Last Update Posted: 2014-07-02
First Post: 1999-11-01

Brief Title: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Sponsor: Yale University
Organization: Yale University

Conditions & Keywords Data

Conditions:
Name
Pheochromocytoma
Brain and Central Nervous System Tumors
Childhood Langerhans Cell Histiocytosis
Gastrointestinal Carcinoid Tumor
Head and Neck Cancer
Intraocular Melanoma
Islet Cell Tumor
Kidney Cancer
Lung Cancer
Melanoma Skin
Neoplastic Syndrome
Neuroendocrine Carcinoma of the Skin
Keywords:
Name View
stage IV renal cell cancer View
recurrent renal cell cancer View
extensive stage small cell lung cancer View
recurrent small cell lung cancer View
metastatic gastrointestinal carcinoid tumor View
recurrent gastrointestinal carcinoid tumor View
gastrinoma View
insulinoma View
recurrent islet cell carcinoma View
thyroid gland medullary carcinoma View
prolactin-producing pituitary tumor View
iris melanoma View
ciliary body and choroid melanoma mediumlarge size View
extraocular extension melanoma View
recurrent intraocular melanoma View
stage IV melanoma View
recurrent melanoma View
WDHA syndrome View
somatostatinoma View
pancreatic polypeptide tumor View
glucagonoma View
childhood Langerhans cell histiocytosis View
metastatic pheochromocytoma View
recurrent pheochromocytoma View
pulmonary carcinoid tumor View
stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity View
recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity View
stage III neuroendocrine carcinoma of the skin View
recurrent neuroendocrine carcinoma of the skin View